<scp>CSF</scp> cytokine, chemokine and injury biomarker profile of glial fibrillary acidic protein (<scp>GFAP</scp>) autoimmunity
Defining the CSF cytokine/chemokine and injury biomarker signature of glial fibrillary acidic protein (GFAP) autoimmunity can inform immunopathogenesis. CSF GFAP-IgG-positive samples (N = 98) were tested for 17 cytokines/chemokines, neurofilament light chain (NfL), and GFAP (ELLA, Bio-Techne). Controls included non-inflammatory (N = 42), AQP4-IgG-positive (N = 83), CNS infections (N = 13), and neurosarcoidosis (N = 32). IL5, IL6, IL10, IL8/CXCL8, CXCL9, CXCL10, CXCL13, BAFF, GM-CSF, IFN-gamma, and TNF-alpha concentrations were higher compared to non-inflammatory controls (P < 0.01). GFAP concentrations were similar to those of AQP4-IgG-positive patients; NfL was higher (P < 0.001) and correlated with MRI changes and outcomes. CSF cytokine/chemokine findings in GFAP autoimmunity correlate with histopathology; GFAP and NfL hold promise as disease biomarkers.
Authors
- Yahel Segal (ORCID: https://orcid.org/0000-0001-6452-9526)
- Michel B. Tolédano (ORCID: https://orcid.org/0000-0002-3079-1179)
- Binxia Yang (ORCID: https://orcid.org/0000-0003-3043-8479)
- Αναστασία Ζεκερίδου (ORCID: https://orcid.org/0000-0002-1960-9065)
- Georgios Mangioris (ORCID: https://orcid.org/0000-0001-5051-1739)
- Ivana Vodopivec
- Eoin P. Flanagan (ORCID: https://orcid.org/0000-0002-6661-2910)
- Andrew B. McKeon (ORCID: https://orcid.org/0000-0001-6856-8143)
- Vanda A. Lennon (ORCID: https://orcid.org/0000-0003-1910-1576)
- John R. Mills (ORCID: https://orcid.org/0000-0003-1025-4760)
- Sean Joseph Pittock (ORCID: https://orcid.org/0000-0002-6140-5584)
- Divyanshu Dubey (ORCID: https://orcid.org/0000-0002-4302-4075)
Institutions
- Roche (Switzerland) (CH)
- Mayo Clinic (US)
Publication Details
- Journal
- Annals of Clinical and Translational Neurology
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1002/acn3.52305
- Citations
- 6
- Primary Topic
- S100 Proteins and Annexins
- Type
- article
- Field-Weighted Citation Impact
- 4.84
Funders
- Mayo Clinic
- National Institutes of Health
- Genentech